Gempharmatech Co. Ltd. A Asset Resilience Ratio

Latest as of June 2025: 23.95%

Gempharmatech Co. Ltd. A asset resilience ratio. Gempharmatech Co. Ltd. A (688046) has an Asset Resilience Ratio of 23.95% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Gempharmatech Co. Ltd. A defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥670.25 Million

≈ $98.08 Million USD Cash + Short-term Investments

Total Assets

CN¥2.80 Billion

≈ $409.51 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio of Gempharmatech Co. Ltd. A (2019–2024)

Asset resilience ratio of Gempharmatech Co. Ltd. A from 2019 to 2024. This chart shows how Gempharmatech Co. Ltd. A's Asset Resilience Ratio has changed over time. Read Gempharmatech Co. Ltd. A (688046) total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Gempharmatech Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Gempharmatech Co. Ltd. A asset portfolio.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥670.25 Million	23.95%
Total Liquid Assets	CN¥670.25 Million	23.95%

Asset Resilience Insights

Good Liquidity Position: Gempharmatech Co. Ltd. A maintains a healthy 23.95% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Gempharmatech Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Gempharmatech Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Gempharmatech Co. Ltd. A Asset Resilience Ratio by Year (2019–2024)

Gempharmatech Co. Ltd. A asset resilience ratio by year from 2019 to 2024. The table below shows the annual Asset Resilience Ratio data for Gempharmatech Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	18.17%	CN¥467.34 Million ≈ $68.39 Million	CN¥2.57 Billion ≈ $376.46 Million	-6.58pp
2023-12-31	24.74%	CN¥637.72 Million ≈ $93.32 Million	CN¥2.58 Billion ≈ $377.18 Million	-10.37pp
2022-12-31	35.11%	CN¥791.24 Million ≈ $115.78 Million	CN¥2.25 Billion ≈ $329.79 Million	+15.59pp
2021-12-31	19.52%	CN¥205.80 Million ≈ $30.11 Million	CN¥1.05 Billion ≈ $154.29 Million	+12.58pp
2019-12-31	6.93%	CN¥26.92 Million ≈ $3.94 Million	CN¥388.14 Million ≈ $56.80 Million	--

pp = percentage points

About Gempharmatech Co. Ltd. A

SHG:688046 China Biotechnology

Market Cap

$1.96 Billion

CN¥13.41 Billion CNY

Market Cap Rank

#6013 Global

#1124 in China

Share Price

CN¥32.70

Change (1 day)

-1.95%

52-Week Range

CN¥13.04 - CN¥40.95

All Time High

CN¥40.95